In this regard, we recently reported that RC-3095 and RC-3940-II can inhibit the growth of MDA-MB-435 cancer by downregulating mainly ErbB-2/HER-2, as well as by decreasing the expression of c-jun and c-fos oncogenes (Bajo et al, 2002). Here, JUN is linked to cancer.